SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

MHRA Approves Gene-Editing Treatment for Children Aged 5 and Over

The UK medicines regulator approved the treatment for children aged 5 and over with serious inherited blood disorders.

Related stories